FCMV

Foresite Capital Management V Portfolio holdings

AUM $80.7M
This Quarter Return
-28.02%
1 Year Return
-24.46%
3 Year Return
+66.81%
5 Year Return
10 Year Return
AUM
$245M
AUM Growth
+$245M
Cap. Flow
-$11.9M
Cap. Flow %
-4.85%
Top 10 Hldgs %
90.75%
Holding
17
New
1
Increased
1
Reduced
4
Closed

Sector Composition

1 Healthcare 92.12%
2 Consumer Staples 5.89%
3 Financials 1.99%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
PRDS
1
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$67.9M 27.72% 9,400,515
THRX
2
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$37M 15.13% 3,212,732
SLGC
3
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$29.9M 12.2% 3,726,472 -1,600,000 -30% -$12.8M
ACRS icon
4
Aclaris Therapeutics
ACRS
$209M
$21.7M 8.86% 1,258,243
HIMS icon
5
Hims & Hers Health
HIMS
$9.57B
$14.4M 5.89% 2,706,922 +1,000,000 +59% +$5.33M
ACET icon
6
Adicet Bio
ACET
$59.9M
$13.6M 5.55% 680,000
QSI icon
7
Quantum-Si Incorporated
QSI
$227M
$11M 4.48% 2,342,061
CGEM icon
8
Cullinan Oncology
CGEM
$445M
$10.4M 4.24% 992,507 -150,499 -13% -$1.58M
KNTE
9
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$9.85M 4.02% 875,001
IVVD icon
10
Invivyd
IVVD
$204M
$6.53M 2.67% 1,431,826 -313,234 -18% -$1.43M
CMPX icon
11
Compass Therapeutics
CMPX
$483M
$6.03M 2.46% 4,400,000
RACB
12
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$4.88M 1.99% 500,000
IRON icon
13
Disc Medicine
IRON
$2.07B
$3.39M 1.38% 2,435,125
HLTH
14
DELISTED
Cue Health Inc. Common Stock
HLTH
$3.16M 1.29% 490,546 -677,236 -58% -$4.37M
ENTA icon
15
Enanta Pharmaceuticals
ENTA
$180M
$3.01M 1.23% +42,250 New +$3.01M
ME
16
DELISTED
23andMe Holding Co. Class A Common Stock
ME
$1.56M 0.64% 406,913
PHVS icon
17
Pharvaris
PHVS
$1.39B
$619K 0.25% 34,142